Phase II trial of irinotecan plus oxaliplatin and 5-fluorouracil/leucovorin in patients with untreated metastatic gastric adenocarcinoma.

J Lee,W K Kang,J M Kwon, S Y Oh, H R Lee, H J Kim,B B Park,H Y Lim,M J Han, J O Park,Y S Park

Annals of Oncology（2007）

引用 33|浏览16

暂无评分

摘要

Background: This nonrandomized open label phase II study evaluated the efficacy and safety of FOLFOXIRI in metastatic or recurrent gastric cancer patients.

查看译文

关键词

gastric cancer,irinotecan,oxaliplatin,chemotherapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要